[1] WHO Scientific Group Report: Recent Advances in Medically Assisted Conception. WHO Technical Report Series 820. Geneva, WHO, 1992. [2] Atamer A, DewAr B, Bayhan G, et al. Serum levels ofleptin and homoeysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters[J]. J Int Med Res, 2008, 36(1):96-105. [3] 彭艳, 吴效科. 多囊卵巢综合征动物模型国内外研究现状[J]. 中医药信息, 2009, 26(6):118-121. [4] 刘艳丽. PCOS大鼠模型的研究现状[J]. 河南医学研究, 2010, l9(1):114-117. [5] Sun F, Yu J.The effect of a special herbal tea on obesity and anovulation in androgen-sterilized rats[J]. Proc Soc Exp Biol Med, 2000, 223:295-301. [6] Liu XW, Kazumiehi A, Hideki M, et a1. Effects of recombinant human FSH(rhFSH),urinary Purified FSH(uFSH), and hMG on small Preantral follicles and tertiary follicles from Normal adult and androgen-sterilized female mice[J]. Fertil Steril, 2000(2):372-380. [7] 王莉, 俞瑾. 中药天癸方对雄激素所致不孕大鼠下丘脑前阿黑皮原mRNA的影响[J]. 中国中西医结合杂志, 2001, 21(7):519-521. [8] Irfan Yavasoglu, Melt Kueuk, Adil Coskun, et al.Polyeystie ovary syndrome and prolactinoma association[J]. Inter Med, 2009, 48(8):611-613. [9] The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome ( PCOS)[J]. Hum Reprod, 2004, 19:41-47. [10] Azziz R, Woods KS, Reyna R, et al.The prevalence and features of the polycystic ovary syndrome in an unselected population[J]. J Clin Endocrinol Metab, 2004, 89:2745-2749. [11] 邓梅先. 胰岛素抵抗与多囊卵巢综合征[J]. 长江大学学报: 自然科学版, 2011, 11(8):181-183. [12] Jones HM, Vernon MW, Rush ME.Systematic studies invalidate the neonatally audrogenized rat as a model for polyeystic ovary disease[J]. Biol Reprod, 1987, 36(5):1253-1265. [13] Toprak S, Yonem A, Cakir B, et al.Insulin resistance in nonobese patients with polycystic ovary syndrome[J]. Horm Res, 2001, 55(2):65-70. |